helenalin has been researched along with Liver Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, B; Huang, Q; Li, C; Li, Y; Lin, X; Wei, Y; Wen, S; Xiong, Y | 1 |
| Bai, F; Fang, B; Huang, Q; Li, Y; Lin, X; Wei, Y; Wen, S; Xiong, Y | 1 |
2 other study(ies) available for helenalin and Liver Cirrhosis
| Article | Year |
|---|---|
Comprehensive analysis of transcriptomics and metabolomics to illustrate the underlying mechanism of helenalin against hepatic fibrosis.
Topics: Animals; Antioxidants; Asteraceae; Carbon Tetrachloride; Disease Models, Animal; Drugs, Chinese Herbal; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Male; Metabolomics; Rats; Rats, Sprague-Dawley; Sesquiterpenes, Guaiane; Signal Transduction; Transcriptome | 2022 |
Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Line; Cell Proliferation; Gene Expression Regulation; Hepatic Stellate Cells; Liver Cirrhosis; MicroRNAs; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Sesquiterpenes, Guaiane; Signal Transduction | 2021 |